Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review
Abstract Objective This systematic search and review aimed to evaluate the available literature on discontinuation of adalimumab and other tumor necrosis factor inhibitors (TNFi) for patients with well-controlled chronic inflammatory arthritides. Methods We conducted a publication search on adalimum...
Saved in:
Main Authors: | Erin Balay-Dustrude, Jessica Fennell, Kevin Baszis, Y. Ingrid Goh, Daniel B. Horton, Tzielan Lee, Chloe Rotman, Anna Sutton, Marinka Twilt, Olha Halyabar, for the CARRA JIA Inactive Disease Workgroup |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | Pediatric Rheumatology Online Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12969-024-01046-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spectrum of spondyloarthritis
by: Himanshu Pathak, et al.
Published: (2020-01-01) -
Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity
by: Aboli Bhingarkar, et al.
Published: (2025-01-01) -
Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01) -
Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells
by: Dana Emerson, et al.
Published: (2025-02-01) -
Psoriatic arthritis: An up to date overview
by: Simon Hackett, et al.
Published: (2020-01-01)